# 11_STAGE_05_DECISION_EVALUATION — PRICEPOINT-001

**SIMULATION / NON-LIVE.** Historical M5 CA_1 analysis. No price change is authorized or released.

**Bound to:** Stage 4 receipt `9536fe9832310cb9b23f8af60862bf7b47b1a3c0b97939146e2d29543f3a664d`; design `08_CONSOLIDATED_CANDIDATE_v5_4` `3cfc71eb5e10c5f680e1768400d03daf05513a23199740ac9f80f8adff2b80ef`; owner ruling R5-Q3; Owner ruling R11.

**Decision owner:** Morgan Lee, Pricing & Revenue Manager (simulated stakeholder). The store GM retains final organizational authority. Human analyst approval remains required.

---

## 1. Direct answer

**For the locked horizon d_1942–d_1969 (2016-05-23 through 2016-06-19), no shelf-price changes should be recommended. The next review is on the four-week cycle.** **[D-01]**

All **2,484 CA_1 items in FOODS_1/2/3 and HOUSEHOLD_1/2** remain `hold_ne` — **hold, not enough evidence**. The GM package is empty, the below-line list is empty, and no diagnostic candidate price should be promoted into the decision package. **[D-02]**

The governing reason is the locked binding backtest. A1 median APE was **0.1824**, inside its **≤ 0.40** limit, while A2 mean signed error was **0.2697**, outside the locked **±0.20** band. `backtest_accept = 0`, so the locked collapse rule applies. **[D-03]**

Confidence is **high** that this is the correct decision under the locked design and validated execution. That confidence applies to the rule-governed `hold_ne` outcome; it does **not** establish that current prices are optimal or that a particular price change would succeed or fail. **[D-04]**

The conclusion remains at the predictive ceiling: under the locked model, no trusted expectation has cleared the gate for pilot use this cycle. Nothing here establishes a causal price effect. **[D-05]**

---

## 2. Strongest evidence

The strongest evidence is the **validated binding backtest**: A1 passed at **0.1824**, A2 failed at **0.2697**, `n_usable = 345`, and the positive sign of A2 means average over-prediction under the locked signed-error definition. **[D-06]**

The resulting action map is also validated: **2,484/2,484** `hold_ne`, with **0** raises, **0** cuts, **0** model-based unchanged actions, **0** legal changes, an empty package, and an empty below-line list. Before collapse, **338** items were trust-eligible and the TE6 usable slice contained **347** items. **[D-07]**

Execution agreement is strong. The two independent Stage 4 paths reconciled **75/75** checked fields with **0** mismatches; the Source Gate passed **24/24**; fixtures passed **26/26** on both paths; and the Stage 4 cross-review ended with **0** unresolved findings. **[D-08]**

The earlier d_1885 stability origin provides sensitivity context only: A1 was **0.1722** and A2 was **0.1794**, with `n_usable = 335` and `U0 = 14`. It is receipt-level, reported-only, and non-binding, so it cannot override the binding result. **[D-09]**

The Stage 4 numerical trace is treated as resolved. The earlier AI 3 claim that there were **346** usable rows arose from omitting `FOODS_3_469` from the unstable-price exclusions. The corrected count confirms the official **345** usable rows and the official A1/A2 values. **[D-10]**

---

## 3. What the evidence does not establish

The evidence does **not** establish that current prices are best, that the expected revenue effect of every possible price change is zero, or that any particular raise or cut would necessarily fail. `hold_ne` is a trust classification, not a finding of price optimality. **[D-11]**

The evidence does **not** establish a causal effect of price on demand or revenue. Price endogeneity, unlabeled promotions, and other accepted design limitations remain outside the claim ceiling. **[D-12]**

The evidence does **not** establish that the model fails at every origin. The d_1885 result is contrary sensitivity evidence in a descriptive sense, but it is non-binding and therefore does not create a competing current-cycle decision. **[D-13]**

The analytical hypothesis is **weakened, not rejected**: the prespecified backtest-miss falsifier fired, while the separate A3/T6 comparison was not produced. **[D-14]**

Whether price variation adds useful predictive information beyond the calendar therefore remains unresolved. A3/T6 is a disclosed gap, but owner ruling R5-Q3 makes it **non-binding and not required for this gate**. Its absence does not weaken the current `hold_ne` decision. **[D-15]**

The **3,654** diagnostic candidate rows covering **1,758** items remain diagnostic only. They are not decision-valid after the collapse and cannot be used to construct a substitute package. **[D-16]**

---

## 4. Most important caveat

**The binding A2 failure is heavily influenced by one small-denominator product.** **[D-17]**

`FOODS_3_092` had realized units of **1** and predicted units of **65.6009**, producing signed error **64.6009**. Its contribution to the reported A2 is **0.1872 of 0.2697** (that is, its signed error of **64.6009** divided by the **345** usable items contributes **0.1872** to the **0.2697** mean signed error). The row itself is validated; the **0.1872** contribution is **coordinator arithmetic on validated per-item rows**, as required by Owner ruling R11. **[D-18]**

This makes a small-denominator / influence explanation a serious alternative interpretation of *why* the mean signed-error gate failed. It does not establish that the rest of the model is correctly calibrated, and it does not identify the underlying operational reason for the low realized units. **[D-19]**

The current lock nevertheless **stands**. Owner ruling R11 preserves the A2 definition, the failed gate, the collapse, and the all-`hold_ne` result for PRICEPOINT-001. No leave-one-out or other counterfactual A2 is a result of this evaluation. **[D-20]**

The appropriate response to this caveat is therefore **future design review**, not a post-result repair of the current decision. **[D-21]**

---

## 5. Specific recommended action

**For the locked horizon d_1942–d_1969 (2016-05-23 through 2016-06-19), Morgan Lee should recommend to the CA_1 store GM that no shelf-price changes be made and that all 2,484 reviewed products remain** `hold_ne`**. The next review is on the four-week cycle.** **[D-22]**

GM package **0 of 25 (N_CAP 25, hard)**; below-line list empty; the list is not padded. No diagnostic candidate should be elevated. **[D-23]**

Any future candidate must still clear the binding A1 and A2 tests before §17.R8 will allow an action, and must then meet ρ̂ ≥ 0.90 (hard) and N_CAP 25. A diagnostic row cannot bypass `backtest_accept = 0`. **[D-24]**

**Caveat beside the action:** the gate failure is strongly influenced by the `FOODS_3_092` small-denominator observation described in §4. That is the most important limitation to communicate with the no-action recommendation, but Owner ruling R11 expressly says it does not license overriding the existing rule. **[D-25]**

The action is proportionate to the evidence. Confidence is high in **no price action under the locked rules** and low in any stronger claim about the true economic response of individual products. **[D-26]**

The principal downside is foregone opportunity: some diagnostic candidates could in reality be useful, but the size and direction of that opportunity cannot be promoted into decision evidence after the trust collapse. **[D-27]**

---

## 6. What to measure next

There is no pilot exposure this cycle, so there is no treatment readout and nothing to roll back. The next governed run should report the same locked A1 and A2 criteria under a design fixed before execution. **Owner:** Morgan Lee (simulated) owns the decision review; the human analyst owns escalation and approval. **Timing:** the next four-week review cycle, or the next governed run, whichever applies. **[D-28]**

Readiness succeeds only if A1 is **≤ 0.40** **and** A2 is within **±0.20**. Failure of either test keeps `hold_ne`. There is no rollback this cycle because nothing is exposed. Any proposal to change A2 or the collapse goes to Stage 3 before execution, not after results. **[D-29]**

The **primary next analytical question**, routed to **Stage 3 under Owner ruling R11**, is:

> **How should the A2 calibration rule handle extreme influence from items with very small realized-unit denominators while preserving A2's intended role as a calibration guardrail?**

That question must be resolved prospectively, before a future execution, rather than by repairing this run after seeing its result. **[D-30]**

A3/T6 remains a **secondary, optional, non-binding** future diagnostic under R5-Q3. An A2 distributional breakdown — such as median signed error, sign balance, or per-item influence — may also be useful in a future governed analysis, but it cannot be used retroactively to bypass this gate. **[D-31]**

A separate data question is whether the very low realized units for `FOODS_3_092` reflect an operational condition not represented in the available data. That explanation remains unresolved and should not be asserted as fact. **[D-32]**

---

## Compact version

### Decision

* **For the locked horizon d_1942–d_1969 (2016-05-23 through 2016-06-19), no price changes are recommended; all 2,484 reviewed products remain** `hold_ne`**. The next review is on the four-week cycle.** **[D-33]**
* **The locked model failed A2:** A1 **0.1824** passed, while A2 **0.2697** failed the **±0.20** band. **[D-34]**
* **The most important caveat is concentration in** `FOODS_3_092`**:** its coordinator-arithmetic contribution is **0.1872 of 0.2697**, but Owner ruling R11 keeps the lock and collapse in force. **[D-35]**

### Primary chart specification

Show the binding d_1913 A1/A2 values against their locked limits, with the d_1885 reported-only values shown separately as non-binding sensitivity context. **[D-36]**

### Next actions

* Route the A2 small-denominator design issue to Stage 3 before any future run. **[D-37]**
* Keep A3/T6 and an A2 breakdown as optional future diagnostics, not current decision prerequisites. **[D-38]**
* Re-evaluate only through the governed process; do not promote the current diagnostic candidate file. **[D-39]**

---

# Technical appendix

## A. Result spine

| Result | Candidate-decision use |
| --- | --- |
| **R-01** | Binding backtest: A1 **0.1824** passes; A2 **0.2697** fails **±0.20**; `backtest_accept = 0`; `n_usable = 345`; U0 excluded **5**. **[D-40]** |
| **R-01s** | Positive signed error means over-prediction under the locked definition. **[D-41]** |
| **R-01c** | `FOODS_3_092`: realized **1**, predicted **65.6009**, signed error **64.6009**; contribution **0.1872 of 0.2697**, labelled coordinator arithmetic. **[D-42]** |
| **R-02** | d_1885: A1 **0.1722**, A2 **0.1794**, `n_usable = 335`, U0 **14**; validated with limitation, receipt-level only, non-binding. **[D-43]** |
| **R-03** | Model settings recorded as penalty **0.0021**, grid index **14**, α **0.5**, threshold **1e-12**, seed **20160522**. **[D-44]** |
| **R-04** | **2,484** `hold_ne`; **0** raises, cuts, unchanged, legal changes, package entries and below-line entries; trust-eligible **338**; TE6 **347**. **[D-45]** |
| **R-05–R-09** | Reconciliation, Source Gate, fixtures, cross-review and owner Validation Gate support execution traceability. **[D-46]** |
| **R-10** | **3,654** candidate rows for **1,758** items; diagnostic only and not decision-valid after collapse. **[D-47]** |
| **Result R-11 (dept MAE)** | Department revenue MAE values exist as validated diagnostics only; they are not a decision-ranking rule and are not compared with capacity. **[D-48]** |
| **G-1** | A3/T6 and the other unproduced twins remain disclosed gaps; R5-Q3 makes them non-binding for this gate. **[D-49]** |
| **G-2** | The twin action field is a disclosed gap; the locked collapse still applies. **[D-50]** |

## B. Evidence-to-action chain

**Validated output → finding → locked rule → decision consequence → recommendation.** **[D-51]**

R-01 establishes the binding gate failure. SF-01 classifies that failure as conclusive for the defined decision question. The locked collapse then governs the trust-eligible subset, while already non-eligible products remain `hold_ne`. R-04 confirms the resulting all-hold action map. Owner ruling R11 adds the required small-denominator caveat but explicitly preserves the result. **[D-52]**

No step in that chain requires a causal interpretation, an optimization claim, or use of the diagnostic candidate file. **[D-53]**

## C. Alternative explanations retained

| Alternative | Assessment | Decision effect |
| --- | --- | --- |
| **Small-denominator / influence** | Strongest caveat because `FOODS_3_092` contributes **0.1872 of 0.2697**; explanation of the underlying low realized units remains unresolved. **[D-54]** | None this cycle under Owner ruling R11. |
| **Common level over-prediction while relative ranking survives** | Coherent but untested. **[D-55]** | Cannot bypass collapse. |
| **Origin-specific calibration drift** | d_1913 and d_1885 differ; d_1885 is non-binding. **[D-56]** | None this cycle. |
| **Price endogeneity / unlabeled promotion effects** | Accepted design limitation. **[D-57]** | Keeps ceiling predictive. |
| **Path-specific implementation error** | Weakened by exact independent reconciliation and passed execution controls. **[D-58]** | Does not explain away the validated collapse. |

## D. Decision-option evaluation

| Option | Candidate evaluation |
| --- | --- |
| **Pilot raise** | Reject this cycle: no raise survives the locked trust gate. **[D-59]** |
| **Pilot cut** | Reject this cycle: no cut survives the locked trust gate. **[D-60]** |
| **Model-based unchanged** | Not available as the analytical label after collapse; operationally, shelf prices simply do not change. **[D-61]** |
| `hold_ne` | Assign to all **2,484** products. This is an insufficient-evidence classification, not an optimal-price finding. **[D-62]** |
| **Override using diagnostic candidates** | Reject. R-10 is diagnostic-only and cannot be promoted after `backtest_accept = 0`. **[D-63]** |
| **Monitor** | Adopt through the next governed A1/A2 evaluation. **[D-64]** |
| **Collect more evidence** | Adopt as a learning path, led by the Stage 3 A2 small-denominator question. **[D-65]** |
| **No price action** | Adopt as the candidate recommendation. **[D-66]** |

## E. Monitoring and learning contract

The primary readiness metrics remain the locked A1 and A2 criteria. Readiness succeeds only if A1 is **≤ 0.40** and A2 is within **±0.20**; failure of either test keeps `hold_ne`. Any proposal to alter A2, its denominator treatment, or the collapse logic belongs to Stage 3 change control plus owner approval before execution. **[D-67]**

There is no rollback action for this cycle because there is no price exposure. **Owner:** Morgan Lee (simulated) owns the decision review; the human analyst owns escalation and approval. **Timing:** the next four-week review cycle, or the next governed run, whichever applies. Any future live pilot requires its own pre-specified monitoring and rollback contract before release. **[D-68]**

The business KPI and all existing candidate guardrails remain locked for any future run; none is loosened by this Stage 5 interpretation. **[D-69]**

## F. Claim-to-evidence ledger

| Claim | Evidence status (§8) | Conclusion type (§10) | Confidence | Evidence | Relevant limitation |
| --- | --- | --- | --- | --- | --- |
| D-01 | Validated | Recommendation | High | R-01, R-04, §17.R8; locked horizon; monitoring plan | Locked horizon and four-week review; applies under current locks only |
| D-02 | Validated | Computed result / recommendation | High | R-04, R-10; locked population | Scope is all 2,484 CA_1 items in the locked departments; `hold_ne` is not price optimality |
| D-03 | Validated | Computed result | High | R-01 | Binding-origin result |
| D-04 | Validated with limitation | Interpretation | High | R-01, R-04–R-09 | Confidence is in rule application, not economics |
| D-05 | Validated with limitation | Interpretation | High | claim ceiling; R-01 | No causal inference |
| D-06 | Validated | Computed result | High | R-01, R-01s | Mean may be influence-sensitive |
| D-07 | Validated | Computed result | High | R-04 | Global collapse masks item heterogeneity |
| D-08 | Validated | Observed fact | High | R-05–R-08 | Execution agreement does not equal model acceptance |
| D-09 | Validated with limitation | Interpretation | High | R-02 | Receipt-level and non-binding |
| D-10 | Validated | Observed fact | High | E-6, R-01 | Corrects superseded AI 3 miscount |
| D-11 | Validated with limitation | Interpretation | High | R-04, R-10 | Individual counterfactual outcomes unknown |
| D-12 | Validated with limitation | Interpretation | High | design ceiling / accepted limitations | Predictive only |
| D-13 | Validated with limitation | Interpretation | Medium-high | R-01, R-02 | Only reported origins available |
| D-14 | Validated with limitation | Interpretation | High | R-01, G-1 | A3/T6 absent |
| D-15 | Validated with limitation | Interpretation | High | G-1, R5-Q3 | Mechanism unresolved |
| D-16 | Validated | Interpretation | High | R-10 | Diagnostic only |
| D-17 | Validated with limitation | Interpretation | High | R-01c, Owner ruling R11 | Concentration does not repair gate |
| D-18 | Validated with limitation | Observed fact / coordinator arithmetic | High for row; high for arithmetic provenance | R-01c, E-7 | `0.1872 of 0.2697` is coordinator arithmetic on validated per-item rows, not a Stage 4 diagnostic result |
| D-19 | Validated with limitation | Interpretation | Medium-high | R-01c, AE-1 | Underlying operational cause unresolved |
| D-20 | Validated | Interpretation / governance | High | Owner ruling R11 | No counterfactual A2 permitted |
| D-21 | Validated | Recommendation | High | Owner ruling R11 | Applies prospectively |
| D-22 | Validated | Recommendation | High | R-01, R-04 | Locked horizon and next four-week review; no claim of optimality |
| D-23 | Validated | Recommendation | High | R-04, R-10 | N_CAP 25 hard; below-line empty; list not padded; foregone opportunity unknown |
| D-24 | Validated | Interpretation | High | locked decision rules | A1/A2 gate precedes ρ̂ ≥ 0.90 and N_CAP 25; diagnostic rows cannot bypass `backtest_accept = 0` |
| D-25 | Validated with limitation | Recommendation caveat | High | R-01c, Owner ruling R11 | Coordinator arithmetic disclosure required |
| D-26 | Validated with limitation | Interpretation | High | R-01, R-04 | True response uncertain |
| D-27 | Unsupported as a quantified claim | Interpretation | Medium | R-10 | Opportunity size is not decision-valid |
| D-28 | Validated | Recommendation | High | R-04; monitoring plan | No current exposure; owner and timing specified |
| D-29 | Validated | Interpretation / monitoring | High | R-01, locked rule | Success/failure thresholds fixed; no rollback this cycle; changes route to Stage 3 before execution |
| D-30 | Validated | Recommendation | High | Owner ruling R11 | Stage 3 question, not current repair |
| D-31 | Validated with limitation | Recommendation | Medium-high | R5-Q3, reconciliation | Optional and non-binding |
| D-32 | Unsupported | Alternative explanation / question | Low as fact | AE-1 / accepted limitation | Operational cause not observed |
| D-33 | Validated | Recommendation | High | R-04 | Locked horizon and four-week review; same limitation as D-22 |
| D-34 | Validated | Computed result | High | R-01 | Binding-origin only |
| D-35 | Validated with limitation | Interpretation | High | R-01c, Owner ruling R11 | Contribution is coordinator arithmetic |
| D-36 | Validated with limitation | Recommendation / communication | High | R-01, R-02 | d_1885 must be visually marked non-binding |
| D-37 | Validated | Recommendation | High | Owner ruling R11 | Prospective design work |
| D-38 | Validated with limitation | Recommendation | Medium-high | R5-Q3, reconciliation | Optional only |
| D-39 | Validated | Recommendation | High | R-10, §17.R8 | Diagnostic rows remain non-decision-valid |
| D-40 | Validated | Computed result | High | R-01 | See Owner ruling R11 caveat |
| D-41 | Validated | Observed fact | High | R-01s | Definition-specific |
| D-42 | Validated with limitation | Observed fact / coordinator arithmetic | High | R-01c | `0.1872 of 0.2697`; share not Stage 4 diagnostic |
| D-43 | Validated with limitation | Computed result | High | R-02 | Receipt-level only |
| D-44 | Validated | Observed fact | High | R-03 | Model settings, not decision justification by themselves |
| D-45 | Validated | Computed result | High | R-04 | Global outcome |
| D-46 | Validated | Observed fact | High | R-05–R-09 | Process validity ≠ model acceptance |
| D-47 | Validated with limitation | Observed fact | High | R-10 | Diagnostic only |
| D-48 | Validated with limitation | Observed fact | High | Result R-11 (dept MAE) | Diagnostic only |
| D-49 | Unsupported / disclosed gap | Observed fact | High | G-1, R5-Q3 | Non-binding |
| D-50 | Disclosed gap | Observed fact | High | G-2 | Collapse still governs |
| D-51 | Validated | Interpretation | High | R-01, R-04, §17.R8 | Depends on locked chain |
| D-52 | Validated with limitation | Interpretation | High | R-01, R-04, Owner ruling R11 | Owner ruling R11 caveat does not change outcome |
| D-53 | Validated with limitation | Interpretation | High | claim ceiling, R-10 | No causal or optimization claim |
| D-54 | Validated with limitation | Alternative explanation | Medium-high | R-01c, Owner ruling R11 | Cause unresolved |
| D-55 | Unsupported / untested | Alternative explanation | Medium | reconciliation AE-2 | Cannot support action |
| D-56 | Validated with limitation | Alternative explanation | Medium | R-01, R-02 | d_1885 non-binding |
| D-57 | Validated with limitation | Alternative explanation | Medium | accepted design limitation | Causal ceiling unchanged |
| D-58 | Validated | Interpretation | High | R-05–R-08 | Does not prove model quality |
| D-59 | Validated | Recommendation | High | R-01, R-04 | Current cycle only |
| D-60 | Validated | Recommendation | High | R-01, R-04 | Current cycle only |
| D-61 | Validated | Interpretation | High | R-04, §17.R8 | Operational no-change ≠ analytical `unchanged` |
| D-62 | Validated | Recommendation / result | High | R-04 | Insufficient evidence, not optimality |
| D-63 | Validated | Recommendation | High | R-10, §17.R8 | Requires future governed redesign to change |
| D-64 | Validated with limitation | Recommendation | High | R-01, R-02 | Future outcome unknown |
| D-65 | Validated | Recommendation | High | Owner ruling R11 | Learning path only |
| D-66 | Validated | Recommendation | High | R-04 | Foregone opportunity unquantified |
| D-67 | Validated | Governance recommendation | High | Owner ruling R11, locked rules | A1/A2 success/failure explicit; any redesign must precede execution |
| D-68 | Validated | Interpretation / recommendation | High | R-04; monitoring plan | No rollback this cycle; owner and timing specified; future pilot needs prospective plan |
| D-69 | Validated | Governance interpretation | High | locked design | No Stage 5 lock change |

## G. Process and evidence limitations

The Stage 4 record retains its accepted limitations. A3/T6 and the other unproduced twins remain disclosed gaps under R5-Q3; the twin action field is also disclosed. None changes the current decision. **[D-70]**

The superseded AI 3 numerical discrepancy is excluded from the evidence chain. The reconciled traceability conclusion is PASS with the process limitation that AI 3's mechanical extracts were not independently hash-verifiable by that auditor. **[D-71]**

Morgan Lee is a simulated stakeholder, and this document remains a simulation artifact rather than a deployment authorization. **[D-72]**

## H. Deployment boundary

This candidate evaluation does not authorize deployment. A future release requires a governed accepted model result, live operational inputs, human release authority, and a monitoring/rollback contract defined before launch. **[D-73]**

The claim ceiling remains predictive expectation only; nothing in this document licenses causal or guaranteed-outcome language. **[D-74]**

### Process, limitation and deployment claim tags

| Claim | Evidence status | Conclusion type | Confidence | Evidence | Limitation |
| --- | --- | --- | --- | --- | --- | --- |
| D-70 | Validated with limitation | Observed fact / interpretation | High | G-1, G-2, R5-Q3 | Disclosed gaps remain |
| D-71 | Validated with limitation | Process interpretation | High | reconciliation; E-6 | Extract-hash limitation remains |
| D-72 | Validated | Observed fact | High | process record | Simulation only |
| D-73 | Validated with limitation | Governance recommendation | High | monitoring plan / locked process | Not deployment approval |
| D-74 | Validated | Interpretation | High | claim ceiling | Predictive only |

---

## Finish Gates

| Gate | Status | Evidence / disposition |
| --- | --- | --- |
| **1 — Input & validation** | **PASS** | R-01–R-10 plus Result R-11 (dept MAE) inventory used; superseded AI 3 numerical claim excluded. |
| **2 — Lock integrity** | **PASS** | No lock changed; Owner ruling R11 preserves A2 and collapse and routes the design gap to Stage 3. |
| **3 — Finding classification** | **PASS** | Conclusive, sensitivity-dependent, unsupported and diagnostic findings remain distinguished. |
| **4 — Inference ceiling** | **PASS (final audits: INFERENCE / EVIDENCE PASS WITH REQUIRED REVISIONS, revisions applied)** | All substantive conclusions stay predictive; no causal price claim is made. |
| **5 — Statistical vs practical** | **PASS (final audits: INFERENCE / EVIDENCE PASS WITH REQUIRED REVISIONS, revisions applied)** | Binding threshold failure is stated beside the Owner ruling R11 influence caveat without counterfactual recomputation. |
| **6 — Alternative explanations** | **PASS** | Small-denominator influence, calibration drift, common-level bias, endogeneity and implementation error are separated from the decision rule. |
| **7 — Traceability** | **PASS (final audits: INFERENCE / EVIDENCE PASS WITH REQUIRED REVISIONS, revisions applied)** | Every numerical claim maps to R-01–R-10, Result R-11 (dept MAE), or addendum E-6/E-7; superseded values are excluded. |
| **8 — Decision evaluation** | **PASS** | Raise, cut, model-based unchanged, `hold_ne`, override, monitor, evidence collection and no-action paths are evaluated. |
| **9 — Proportionality** | **PASS (after final-audit revisions V-1..V-4)** | No price action is proportionate to a failed locked trust gate; opportunity cost is acknowledged but not quantified from diagnostic evidence. |
| **10 — Monitoring & learning** | **PASS (after final-audit revisions V-1..V-4)** | A1/A2 readiness, Stage 3 escalation, optional diagnostics and the no-current-rollback condition are specified. |
| **11 — Communication & ownership** | **PENDING human analyst approval** | Candidate document is ready for human analyst approval. |

---

## Constructor objections

**None.** **[D-75]**

The constructor accepts the reconciliation resolutions used in this candidate document: the official R-01 values stand; d_1885 is sensitivity-only and non-binding; Owner ruling R11's `FOODS_3_092` contribution is the leading caveat; the A2 small-denominator issue is routed to Stage 3; A3/T6 remains secondary and non-binding; and the current decision remains no price action with all products `hold_ne`. **[D-76]**

### Constructor-objection claim tags

| Claim | Evidence status | Conclusion type | Confidence | Evidence | Limitation |
| --- | --- | --- | --- | --- | --- |
| D-75 | Validated | Constructor judgment | High | reconciled record | No independent objection raised |
| D-76 | Validated | Constructor judgment / synthesis | High | 08_ reconciliation; R5-Q3; Owner ruling R11 | Applies to this candidate construction |


END 11_STAGE_05_DECISION_EVALUATION
